Acute Graft Versus Host Disease - 162 Studies Found Completed : Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation : Myelodysplastic Syndromes Leukemia, Myeloid, Acute Leukemi : 2014-04-15 : Radiation: Dynamic contrast-enhanced computed tomography Recruiting : A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant : Acute Myeloid Leukemia (AML) Chronic Myelogenous Leukemia (CML) Drug: CD24Fc Drug: Methotrexate Completed : Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract : Graft Versus Host Disease : 2014-06-25 : Drug: Natalizumab Other Name: Completed : Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant : Breast Cancer Chronic Myeloproliferative Disorders Gestati : 2006-12-11 : Biological: alemtuzumab Drug: methylpredni Completed : Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation : Chronic Myeloproliferative Disorders Graft Versus Host Disease Drug: mycophenolate mofetil Drug: tacrolim Completed : Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation : Graft vs Host Disease : 2010-08-02 : Drug: Atorvastatin calcium (Lipitor) 40 mg PO daily Completed : Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant : Cancer : 2006-07-26 : Drug: methotrexate Drug: methylprednisolon Active, not recruiting : Phase II Open Label Trial Of Tacrolimus/Methotrexate And Tocilizumab For The Prevention Of Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation : Hematopoietic Stem Cell Transplantation : 2014-07-30 : Drug: Tacrolimus Patients enro Completed : In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease : Graft Versus Host Disease : 2011-10-13 : Drug: Cyclophospahmide and Sirolimus Completed : Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation : Chronic Myeloproliferative Disorders Graft Versus Host Disease Drug: methotrexate Drug: sirolimus <<< Previous | Next >>>
